FR2497669B1 - Preparation pharmaceutique ayant d'excellentes proprietes d'absorption - Google Patents
Preparation pharmaceutique ayant d'excellentes proprietes d'absorptionInfo
- Publication number
- FR2497669B1 FR2497669B1 FR8200357A FR8200357A FR2497669B1 FR 2497669 B1 FR2497669 B1 FR 2497669B1 FR 8200357 A FR8200357 A FR 8200357A FR 8200357 A FR8200357 A FR 8200357A FR 2497669 B1 FR2497669 B1 FR 2497669B1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical preparation
- absorption properties
- excellent absorption
- properties
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000010521 absorption reaction Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/80—Falling particle mixers, e.g. with repeated agitation along a vertical axis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56003263A JPS57118509A (en) | 1981-01-14 | 1981-01-14 | Novel preparation of high absorbability |
JP18150881A JPS57146723A (en) | 1981-03-06 | 1981-11-11 | Pharmaceutical preparation having improved absorption |
JP56184861A JPS5885813A (ja) | 1981-11-17 | 1981-11-17 | 吸収性良好な製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2497669A1 FR2497669A1 (fr) | 1982-07-16 |
FR2497669B1 true FR2497669B1 (fr) | 1987-08-21 |
Family
ID=27275728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8200357A Expired FR2497669B1 (fr) | 1981-01-14 | 1982-01-12 | Preparation pharmaceutique ayant d'excellentes proprietes d'absorption |
Country Status (3)
Country | Link |
---|---|
FR (1) | FR2497669B1 (sv) |
GB (1) | GB2092002B (sv) |
SE (1) | SE460638B (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4900730A (en) * | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
JPS58140026A (ja) * | 1982-01-14 | 1983-08-19 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
US4476116A (en) * | 1982-12-10 | 1984-10-09 | Syntex (U.S.A.) Inc. | Polypeptides/chelating agent nasal compositions having enhanced peptide absorption |
US4542020A (en) * | 1984-08-17 | 1985-09-17 | E. R. Squibb & Sons, Inc. | Long-lasting adhesive antifungal suppositories |
NL8701143A (nl) * | 1986-05-27 | 1987-12-16 | Sandoz Ag | Farmaceutische preparaten. |
US5554388A (en) * | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
IT1244500B (it) * | 1991-03-21 | 1994-07-15 | Pulitzer Italiana | Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana |
US5571788A (en) * | 1991-12-09 | 1996-11-05 | Ciba-Geigy Corporation | Stable calcitonin pharmaceutical compositions |
CA2399505C (en) | 2000-02-04 | 2012-01-03 | Unigene Laboratories, Inc. | Nasal calcitonin formulations |
JP2006515629A (ja) * | 2003-01-23 | 2006-06-01 | シャイア ラボラトリーズ,インコーポレイテッド | 吸収促進剤 |
CN102727870B (zh) | 2006-09-27 | 2014-04-30 | 旭化成制药株式会社 | 鲑降钙素的应用 |
EP2502632B1 (en) | 2009-11-18 | 2016-12-28 | Asahi Kasei Pharma Corporation | Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB761809A (en) * | 1953-09-02 | 1956-11-21 | Merck & Co Inc | Solid pharmaceutical preparation containing streptomycin and/or dihydrostreptomycin |
GB1061426A (en) * | 1964-05-22 | 1967-03-15 | Olin Mathieson | Water-soluble penicillin composition |
GB2051574B (en) * | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
AU541247B2 (en) * | 1979-12-20 | 1985-01-03 | R.P. Scherer Corporation | Adjuvants for rectal delivery of drug substances |
-
1982
- 1982-01-11 SE SE8200103A patent/SE460638B/sv not_active IP Right Cessation
- 1982-01-11 GB GB8200670A patent/GB2092002B/en not_active Expired
- 1982-01-12 FR FR8200357A patent/FR2497669B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
SE460638B (sv) | 1989-11-06 |
SE8200103L (sv) | 1982-07-15 |
GB2092002B (en) | 1985-09-11 |
GB2092002A (en) | 1982-08-11 |
FR2497669A1 (fr) | 1982-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2509175B1 (fr) | Preparation therapeutique ayant d'excellentes proprietes d'absorption | |
DE3176086D1 (en) | Mucopolysaccharides having biological properties; their preparation and use as medicines | |
IT1148006B (it) | Ammidi dotate di proprieta' farmaceutiche e loro preparazione | |
FR2627944B3 (fr) | Groupeur d'andains | |
IT1150622B (it) | Polisaccaridi dotati di attivita' ant-carcinogena e procedimento per la loro preparazione | |
BE894376A (fr) | Preparation pharmaceutique | |
FI875457L (fi) | Skarvning av dukars aendor. | |
IT8324035A0 (it) | Cefem composti ad attivita'farmaceutica e procedimenti per laloro preparazione. | |
FR2497669B1 (fr) | Preparation pharmaceutique ayant d'excellentes proprietes d'absorption | |
IT8124141A0 (it) | Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina. | |
BE893302A (fr) | Procede de preparation de carbonates d'alkylene | |
RO83114A (ro) | Procedeu pentru prepararea ditiazolil-(2,2')-disulfurilor | |
DE3272028D1 (de) | Preparation of polyalkylene polyamines | |
FR2506313B1 (fr) | Derives de l'acide n-acetylneuraminique et leur preparation | |
BE890376R (fr) | Preparation d'acetaldehyde | |
BE895205A (fr) | Procede de preparation de carbonates d'alkylene | |
FR2497795B1 (fr) | Catalyseur d'oxydeshydrogenation | |
FR2583416B1 (fr) | Composition d'aminobenzylamines. | |
FR2601955B1 (fr) | Procede de preparation d'alkyl et d'arylchlorosilane | |
FR2566401B1 (fr) | Procede de preparation d'olefines fluorees et nouvelles olefines en resultant | |
FR2509815B1 (fr) | Accouplement d'arbres | |
ES516534A0 (es) | "procedimiento de preparacion de 2-isopropilamino-pirimidina-n-oxido". | |
ES542334A0 (es) | "procedimiento de preparacion de monomeros de estireno de anillo halogenado" | |
BE880941A (fr) | Preparation d'acetaldehyde | |
FR2538054B1 (fr) | Piton d'ameublement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |